←
Bench Side Story246 posts
Bench Side Story avatar

Bench Side Story

@BenchSideStory

Looks at the impact of evidence based medical research globally, the researchers involved and the progress made leading to proven discovery on population health

◷ Joined March 2020▧ 216 Photos and videos
Bench Side Story avatar
Bench Side Story@BenchSideStory·Nov 16

CELLULAR AND MOLECULAR MECHANISMS OF SKELETAL MUSCLE REPAIR AND REGENERATION With Esther García-Domínguez @Esther_GD_ Postdoctoral Research Fellow Australian Regenerative Medicine Institute @ARMI_Labs Monash University @MonashUni, Victoria, Australia RESEARCHER PROFILE Filmed in Adelaide, Australia | May 2026 Dr Esther García-Domínguez is a Postdoctoral Research Fellow at the Australian Regenerative Medicine Institute (ARMI), Monash University, where she investigates the cellular and molecular mechanisms of skeletal muscle repair and regeneration, with a particular focus on ageing and exercise. Esther obtained her PhD in 2023 from the University of Valencia, Spain, conducting research in collaboration with the Spanish National Centre for Cardiovascular Research (CNIC) @cnic_cardio and Victoria University @victoriauninews, Australia. Her doctoral research explored the molecular mechanisms of skeletal muscle ageing and frailty, particularly how mitochondrial remodelling and exercise contribute to preserving muscle health and physical function. In 2024, Esther joined Dr William Roman’s laboratory at ARMI, expanding her research into muscle cell biology and regeneration. Her current work focuses on understanding how muscle fibres repair themselves following physiological damage, how ageing compromises this process, and how communication between different cell populations within skeletal muscle coordinates tissue repair and regeneration. She combines advanced microscopy, spatial biology and multi-omics approaches with experimental models and human samples to investigate skeletal muscle adaptation across molecular, cellular and tissue levels. Esther has contributed to 27 peer-reviewed publications, including studies in Nature, Science and PNAS, and presented her research at over 40 national and international conferences. Her contributions have been recognised through competitive fellowships, research grants and scientific awards. Beyond the laboratory, Esther is committed to scientific leadership, mentorship and community engagement. She chairs ARMI’s Postdoctoral Committee, serves on its Student Programs Committee and has represented ARMI in Melbourne Emerging Leaders in Biomedical Research and Science Meets Parliament, promoting scientific collaboration, professional development and engagement with policymakers. Collaborations include Altos Labs @altos_labs, BGI, National Institute on Aging (NIA) (NIA, NIH), Spanish National Centre for Cardiovascular Research (CNIC), University of Valencia @UV_EG and Institute for Health and Sport (Victoria University). Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

5:09
Bench Side Story avatar
Bench Side Story@BenchSideStory·Nov 6

PHYSIOTHERAPIST-LED CARE FOR MUSCULOSKELETAL CONDITIONS IN THE EMERGENCY DEPARTMENT With Associate Professor Gustavo Machado University of Sydney @Sydney_Uni & NHMRC Principal Research Fellow, Institute for Musculoskeletal Health @msk_health, Australia RESEARCHER PROFILE Filmed in Sydney, Australia | November 2026 Associate Professor Gustavo Machado is a physiotherapist and health services researcher at the University of Sydney and the Institute for Musculoskeletal Health, Sydney Local Health District. He holds an NHMRC Investigator Fellowship (EL2) and a University of Sydney Robinson Fellowship. With over 15 years of research experience, he leads a program focused on transforming musculoskeletal and emergency care through evidence-based practice. His research involves large-scale clinical trials evaluating treatments for musculoskeletal pain, strategies to reduce low-value care, and innovative models of emergency, hospital and virtual care. His work aims to improve patient outcomes, healthcare efficiency and health system sustainability. Associate Professor Machado has published over 150 peer-reviewed papers in leading journals, including The Lancet, The BMJ, The Lancet Rheumatology and JAMA Health Forum, attracting more than 6,500 citations. He ranks among the world's top 2% of scientists (Stanford/Elsevier), and his research has informed over 100 policy documents across 17 countries. He has secured $29 million in competitive research funding as a Chief Investigator and received 30 research and impact awards, including the Research Australia Award, ANZMUSC Trial of the Year and NSW Health Secretary's Award. Funding for Associate Professor Machado's research has included National Health and Medical Research Council (NHMRC) @NHMRC, Medical Research Futures Fund, HCF Australia Research Foundation and Ramsay Hospital Research Foundation. His collaborations include NSW Ambulance @NSWAmbulance, NSW Agency for Clinical Innovation @nswaci, Australian Physiotherapy Association @apaphysio, Australasian College for Emergency Medicine and the Australian & New Zealand College of Emergency Nursing. He contributes to national research and health policy committees, including the NHMRC, Australasian College for Emergency Medicine and ANZMUSC. He is a Fellow of the International Society for Quality in Health Care and a member of the Royal Society of NSW @royalsocnsw. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

12:40
Bench Side Story avatar
Bench Side Story@BenchSideStory·Nov 1

3D PRINTING, BIOPRINTING & STEM CELL TECH IN ARTICULAR CARTILAGE REGENERATION AND TREATING OSTEOSARCOMA With Associate Professor Claudia Di Bella @Claudiadibella_ Orthopaedic surgeon, Melbourne, Australia & Associate Professor of Surgery, University of Melbourne, Australia & Chair, Australian Orthopaedic Association (AOA) Research Foundation RESEARCHER PROFILE Filmed in Sydney, Australia | November 2026 Associate Professor Claudia Di Bella is an academic orthopaedic surgeon based in Melbourne, specialising in orthopaedic oncology and complex joint reconstruction. Originally trained at the world-renowned Rizzoli Orthopaedic Institute in Bologna, Italy, (IRCCS Istituto Ortopedico Rizzoli) she moved to Australia in 2010. She was awarded Fellowship of the Royal Australasian College of Surgeons in 2013 and Fellowship of Australian Orthopaedic Association (AOA) in 2014. She is Associate Professor of Surgery at the University of Melbourne and leads a translational research program focused on tissue engineering and innovative solutions to improve outcomes for patients with musculoskeletal disease, in particular bone sarcomas. Her research has attracted over AUD $6 million in competitive funding, including an NHMRC–MRFF Clinical Investigator Grant, and has resulted in more than 60 peer-reviewed publications, book chapters and numerous national and international presentations. She is passionate about bridging the gap between scientific discovery and meaningful improvements in patient care. As an Associate Professor of Surgery at the University of Melbourne, she is the clinical lead of the cartilage regeneration program and osteosarcoma 3D printing program at the Biofab3D, part of the Aikenhead Centre for Medical Discovery (ACMD). Clinically, A/Prof Di Bella is one of Australia’s few orthopaedic oncology surgeons, managing complex bone and soft tissue tumours and performing high-volume limb salvage surgery and joint reconstruction. Her work combines surgical expertise, innovation and multidisciplinary care for patients facing life-changing diagnoses. Beyond her clinical and academic roles, Claudia is a strong advocate for diversity, inclusion and representation in medicine. Through national and international leadership roles, including within orthopaedic surgery and sarcoma organisations, she actively mentors the next generation of surgeons and researchers, with a particular commitment to supporting women and underrepresented groups in STEMM and surgical careers. Source: Supplied and supplemented SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

8:54
Bench Side Story avatar
Bench Side Story@BenchSideStory·Oct 24

DRUG DELIVERY OF TARGETED THERAPIES FOR PANCREATIC CANCER, MOTOR NEURONE DISEASE Associate Professor Kara Vine-Perrow, Deputy Director Community Partnerships and Impact, Molecular Horizons Research Institute, University of Wollongong @UOW & Group Leader, Targeted Cancer Therapeutics Research Laboratory, University of Wollongong, New South Wales, Australia RESEARCHER PROFILE Filmed in Wollongong, New South Wales, Australia | October 2026 Associate Professor Kara Vine-Perrow is a cancer researcher, educator and research leader in the Faculty of Science, Medicine & Health at the University of Wollongong, where she serves as Deputy Director (Community Partnership and Impact) of the Molecular Horizons Research Institute and leads the Targeted Cancer Therapeutics Laboratory. Her research focuses on developing innovative drug delivery technologies, implantable medical devices and RNA-based therapeutics for difficult-to-treat diseases, with a particular emphasis on pancreatic cancer and motor neurone disease. Assoc Prof Vine-Perrow is internationally recognised for her work in translational therapeutics, advancing discoveries from the laboratory towards clinical application through partnerships with clinicians, industry, government and patient advocacy organisations. She leads multidisciplinary programs that combine nanomedicine, biomaterials and localised drug delivery to improve treatment outcomes for patients with limited therapeutic options. A key focus of her research is ResectAssist™, an implantable drug delivery platform designed to deliver therapeutics directly to pancreatic tumours. Supported by funding from the NHMRC @nhmrc , Cancer Institute NSW @cancerNSW , Australian Economic Accelerator, FightMND @FightMND , and Tour de Cure @tourdecure_aus , her research aims to accelerate the translation of innovative therapeutics and medical technologies from the laboratory to patient care. She also works closely with industry partners to accelerate commercialisation and real-world patient impact. Beyond research, Assoc Prof Vine-Perrow is passionate about mentoring the next generation of scientists and has supervised numerous PhD and Honours students into successful careers across academia, healthcare and industry. She is committed to ensuring that research outcomes translate into meaningful improvements patients and the broader community. Source and images: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

6:49
Bench Side Story avatar
Bench Side Story@BenchSideStory·Oct 20

RESEARCH IMPACT: 32 YEARS OF UNDERSTANDING, DIAGNOSING, TREATING & PREVENTING THE ONSET OF HEART DISEASE With Professor Jason Kovacic CEO & Institute Director, Victor Chang Cardiac Research Institute & Practicing Clinical Cardiologist, St Vincent's Hospital, Sydney Australia & Professor of Medicine The Icahn School of Medicine at Mount Sinai @IcahnMountSinai New York, United States RESEARCH IMPACT Filmed in Sydney, Australia | October 2026 The Victor Chang Cardiac Research Institute is dedicated to finding cures for cardiovascular disease through world-class and cutting-edge medical research. The Institute's team seeks to discover better ways of understanding, diagnosing, treating, and preventing the onset of heart disease. It is committed to ensuring its research breakthroughs are rapidly translated into advances in clinical care. The Victor Chang Cardiac Research Institute was founded in 1994 in honour of the legendary heart transplant surgeon Dr Victor Chang AC. In 1996, the late Diana, Princess of Wales, officially opened the institute in Sydney, Australia. Beginning with just two scientists, it has more than 250 scientists, doctors, and staff working together across 26 laboratories nationwide. It is renowned for the quality of its scientific discoveries worldwide. In 2022, the Institute expanded its national footprint by establishing a new heart disease research hub in partnership with The University of Western Australia and in 2025 announced a new collaboration with the Perth-based Harry Perkins Institute of Medical Research. It has also established hubs in South Western Sydney and Melbourne. This is allowing researchers and scientists to accelerate life-saving discoveries that benefit all Australians and deliver international impact. The Institute is also a proud partner of the St Vincent’s Sydney Health Innovation Precinct - comprised of St Vincent’s Hospital Sydney, the Garvan Institute of Medical Research, St Vincent’s Private Hospital Sydney and St Vincent’s Clinic. In this interview on the impact of research undertaken by the Victor Chang Cardiac Research Institute, Professor Jason Kovacic talks about the following studies: - Funnel web spider venom to develop world’s first cardiac protective drug for heart transplants and heart attacks doi.org/10.1161/CIRCULATIONA… - Discovery and role of PHACTR1 gene in vascular diseases including spontaneous coronary artery dissection (SCAD) doi.org/10.1016/j.jacc.2018.… - Artificial intelligence and machine learning to predict disease progression & better outcomes of aortic stenosis doi.org/10.3389/fcvm.2023.11… Source: Victor Chang Cardiac Research Institute website SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

11:25
Bench Side Story avatar
Bench Side Story@BenchSideStory·Oct 10

LARGE-SCALE CLINICAL AND POPULATION-BASED RESEARCH Professor Christopher Reid, Cardiovascular Epidemiologist & Research Professor, School of Public Health & Preventive Medicine, Monash University @MonashUni , Victoria, Australia & School of Population Health at Curtin University @CurtinMedia , Western Australia & Chair, Australian Clinical Trials Alliance (ACTA) @ACTA_org RESEARCHER PROFILE Filmed in Perth, Australia | October 2026 Christopher Reid is an internationally renowned cardiovascular epidemiologist with appointments as a Research Professor in both the School of Population Health at Curtin University and the School of Public Health and Preventive Medicine, at Monash University. He was re-appointed as a John Curtin Distinguished Professor in 2021 and is currently Director of the Monash and Curtin Centre for Clinical Research and Education (CCRE). He has been awarded over $178M as a Chief Investigator and has received continuous NHMRC funding since 2001. His major research interests include clinical outcome registries, randomised controlled trials, and epidemiological cohort studies. He has over 820 peer-reviewed publications (with over 44000 citations and a H-Index of 91) many of which are in leading journals including the New England Journal of Medicine, the Lancet, JAMA, JACC, and the BMJ. He is a Chief Investigator for the Colchicine in Type 2 diabetes trial (COLCOT-T2D), the Aspirin in the Elderly (ASPREE) trial, the HOPE-3 trial, the Statins in Reducing Events in the Elderly (STAREE) trial and the LEADER-PAD trial. He is also the research director for the Australian and New Zealand Cardiothoracic database (ANZSCTS) registry and the Victorian Cardiac Outcomes registry (VCOR). He is the Board Chair of the Australian Clinical Trials Alliance (ACTA) and a board member of the Australian New Zealand Alliance for Cardiovascular Trials (ANZACT) Network and the Australian Cardiovascular Alliance (ACVA). Prof Reid has trained more than 30 PhD students to completion and undertaken assignments for the World Health Organization in cardiovascular disease prevention in the Asia Pacific Region. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

8:00
Bench Side Story avatar
Bench Side Story@BenchSideStory·Oct 10

APPLICATIONS OF LONG-READ SEQUENCING IN CLINICAL GENOMICS Dr Ira Deveson, Laboratory Head, Genomic Technologies Research Lab, Garvan Institute of Medical Research @GarvanInstitute, Sydney, Australia RESEARCHER PROFILE Filmed in Sydney, Australia | October 2026 Dr Ira Deveson is a mid-career researcher and Snow Fellow. He has expertise in clinical genomics, biotechnology development and bioinformatics, with his lab focusing on applications of long-read sequencing in clinical genomics. His work spans from computational methods development and software/hardware engineering, to large-scale genomic analysis of diverse cohorts in health and disease. Dr Ira Deveson graduated with a Bachelor of Philosophy from the Australian National University in 2012. He completed a PhD at the Garvan Institute of Medical Research from 2014-2017, supervised by Prof John Mattick and Dr Tim Mercer. Dr Deveson's PhD focused on genome/transcriptome research and bioinformatics, and earned him recognition with the JD Catcheside prize from the Genetics Society of Australasia. Dr Deveson was appointed as Head of Garvan's Genomic Technologies Lab in 2020 and has since been awarded multiple significant NHMRC and MRFF grants to support his work on long-read sequencing technology development. He currently holds an NHMRC Investigator Grant (L1) and a prestigious Snow Medical Fellowship. His research has been published in leading science journals including Nature, Nature Biotechnology and Nature Methods. In addition to his research role, Dr Deveson leads the Long-read Sequencing Hub within Garvan’s Genomics Platform. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

6:54
Bench Side Story avatar
Bench Side Story@BenchSideStory·Oct 6

IDENTIFYING BIOMARKERS FOR IMMUNOTHERAPY USING SPATIAL BIOLOGY With Associate Professor Arutha Kulasinghe @aruthak, Chair in Spatial Medicine and Principal Research Fellow, Frazer Institute, University of Queensland @UQ_News, & Founding Scientific Director, Queensland Spatial Biology Centre @Qld_SBC, Wesley Research Institute @WesleyResearch, Queensland, Australia RESEARCHER PROFILE Filmed in Sydney, Australia | October 2026 Associate Professor Arutha Kulasinghe is a Principal Research Fellow at The University of Queensland's Frazer Institute, where he leads the Clinical-oMx Lab. He holds the inaugural Brazil Family Chair in Spatial Medicine and is the founding Scientific Director of the Queensland Spatial Biology Centre at the Wesley Research Institute. He completed his PhD at Queensland University of Technology. A/Prof Kulasinghe is a pioneer of spatial biology in the Asia-Pacific region and among the first to apply spatial transcriptomics, proteomics and interactomics there. He combines these technologies in an integrated multi-omics approach to understand the biology that drives disease. His research centres on immuno-oncology in lung, skin, and head and neck cancers, with a particular focus on the tumour microenvironment and on finding biomarkers that predict which patients will respond to immunotherapy. He also develops liquid biopsy approaches for lung and head and neck cancer, and has led tissue-atlas studies of infectious diseases, including COVID-19 and pandemic influenza. He has authored more than 120 peer-reviewed publications, in journals including Nature Genetics, Nature Communications, The Lancet Microbe and the Journal of Clinical Oncology. His honours include Cure Cancer's Researcher of the Year (2023), The Australian's Top Innovators (2024), a Research Australia UNSW Frontiers Award (2026) and InDaily Queensland's 40 Under 40 (2026). He has also been named on The Courier-Mail's Queensland Power Lists for technology and medicine (2026). His work is supported by the MRFF, NHMRC, US Department of Defense, Cancer Australia, Cure Cancer, industry, and hospital and philanthropic partners. Source: Supplied Media Access Credit: Research Australia 2025-26 Health and Medical Research Awards @ResAustralia SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

8:16
Bench Side Story avatar
Bench Side Story@BenchSideStory·Oct 5

VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA With Jessica Lo, Research Associate Centre for Healthy Brain Ageing (CHeBA), @UNSW Sydney New South Wales, Australia RESEARCHER PROFILE Filmed in Sydney, Australia | October 2026 Jessica Lo (Jess) is a Research Associate at the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, Australia. For over seven years, she has been instrumental in leading and coordinating research for the international Stroke and Cognition Consortium (STROKOG), collaborating with global experts to address key questions related to vascular cognitive impairment and dementia. With a strong background in Medical Statistics and extensive experience as a biostatistician, including working on clinical trials at King’s College London, Jess’s research focuses on post-stroke cognitive decline and dementia. She published five first-authored papers in high-impact journals on topics such as the prevalence of post-stroke cognitive impairment across ethno-regional groups and the trajectory of cognitive decline after stroke. Her work, which has garnered over 1,360 citations, has been featured in international media. Jess has presented her research at more than 10 national and international conferences and has been invited to speak at global events. Committed to translating her findings into clinical practice, she aims to provide healthcare professionals with evidence-based strategies to prevent or delay the onset of dementia and improve long-term outcomes for stroke survivors. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

3:44
Bench Side Story avatar
Bench Side Story@BenchSideStory·Sep 29

POTASSIUM-ENRICHED SALT IN THE MANAGEMENT OF HYPERTENSION Dr Katrina Kissock @KatrinaKissock Accredited Practicing Dietitian Research Fellow, Nutrition Implementation Research and Food Policy, The George Institute for Global Health @georgeinstitute Sydney, Australia & Heart Foundation Postdoctoral Fellow @heartfoundation & Conjoint Lecturer Faculty of Medicine and Health UNSW, Sydney, Australia @UNSW RESEARCHER PROFILE Filmed in Sydney, Australia | September 2026 Dr Katrina Kissock is a Research Fellow in Nutrition Implementation Research and Food Policy at The George Institute for Global Health, as well as a Heart Foundation Postdoctoral Fellow and Conjoint Lecturer in the Faculty of Medicine and Health at UNSW. Her work is positioned at the intersection of nutrition, cardiovascular disease prevention, and public health, with a particular focus on global strategies to reduce sodium intake and improve heart health. Dr Kissock’s research primarily centres on scaling up the switch from regular salt to potassium-enriched salt, aiming to save thousands of lives worldwide by reducing the burden of cardiovascular disease. She also leads research on whole grains, examining their health benefits, how they are defined, developing global recommendations, and translating these messages for consumers. Her expertise spans cardiovascular disease, sodium reduction, whole grains, dietary intake, and public health, and she has contributed to research and collaborations across a number of countries including Nigeria, China, Sri Lanka, the United States, United Kingdom, Fiji, Sweden, France, and Denmark. Her work is designed to inform and influence public health policy, clinical guidelines, and food industry practices, supporting the adoption of evidence-based nutrition interventions at scale. Dr Kissock is also an Accredited Practising Dietitian with experience in chronic disease and youth mental health, further strengthening her impact across research, practice, and mentoring. Source: Supplied Media access credit: PSA26 National Conference, Pharmaceutical Society of Australia (PSA), Sydney, Australia July 2026 SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

6:37
Bench Side Story avatar
Bench Side Story@BenchSideStory·Sep 21

GUT MICROBIOME AND GASTROINTESTINAL DYSFUNCTION IN PEOPLE WITH AUTISM Vic Lin, Final Year PhD Candidate, Gut-Brain Axis Laboratory, RMIT University @RMIT Melbourne, Australia RESEARCHER PROFILE Filmed in Melbourne, Australia | September 2026 Vic Lin is a final-year PhD student in the Gut-Brain Axis Laboratory at RMIT University in Melbourne, Australia. His research focuses on understanding the gastrointestinal dysfunction commonly experienced by people with autism and exploring the connection between the gut microbiome and gastrointestinal function. Vic completed his bachelor’s degree with honours at the Florey Institute of Neuroscience and Mental Health before starting his PhD at RMIT University. His PhD investigates how metabolites produced by the gut microbiome may influence gastrointestinal physiology in autism. Using a mouse model of autism, Vic examines key aspects of gut function, including intestinal permeability and gut motility, and investigates whether these changes can be improved using a treatment designed to target potentially harmful microbial metabolites. His research has been presented at conferences across Australia, including the Australasian Neurogastroenterology and Motility Association and the Australasian Society for Autonomic Neuroscience in 2025. Through his work, Vic aims to further the understanding of the gut-microbiome connection in autism and contribute to the development of novel therapeutic strategies for gastrointestinal dysfunction to improve outcomes for people with autism. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

6:35
Bench Side Story avatar
Bench Side Story@BenchSideStory·Sep 13

IMMUNE MECHANISMS OF COELIAC DISEASE AND GLUTEN-RELATED DISORDERS With Professor Jason Tye-Din, Director, Snow Centre for Immune Health & Head of the Coeliac Research Laboratory at WEHI @WEHI_research & Gastroenterologist, Royal Melbourne Hospital & Clinician Researcher, Melbourne, Australia RESEARCHER PROFILE Filmed in Melbourne | September 2026 Professor Jason Tye-Din is head of the Coeliac Research Laboratory at WEHI and a gastroenterologist at the Royal Melbourne Hospital. His expertise spans the immune mechanisms of coeliac disease, clinical care of gluten-related disorders, diagnostic discovery and pre-clinical and clinical drug development. His work aims to improve the health and quality of life of people suffering gastrointestinal immune diseases, particularly those caused by gluten and other foods. Professor Tye-Din is a Principal Research Fellow at the University of Melbourne, Honorary Research Fellow at the Murdoch Children’s Research Institute and is involved in multiple leadership and advisory roles, including to the World Health Organisation and industry. As a recognised leader in immunology and translational science, Professor Tye-Din’s research has been widely published. Most recently, he led the development of a ground-breaking blood test that has the potential to transform the way coeliac disease is diagnosed. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

7:16
Bench Side Story avatar
Bench Side Story@BenchSideStory·Aug 15

INFLUENCE OF GUT MICROBES AND INFLAMMATION ON BRAIN FUNCTION AND BEHAVIOUR IN AUTISM With Angela Renata Jiménez Perez, PhD Candidate, Gut-Brain Axis Laboratory, RMIT University @RMIT Melbourne, Australia RESEARCHER PROFILE Filmed in Melbourne, Australia | August 2026 Third-year PhD candidate Angela Jimenez is part of the Gut-Brain Axis Laboratory at RMIT University in Melbourne, Australia. Angela holds a bachelor's degree in neuroscience (Honours) from the National Autonomous University of Mexico (UNAM), and her doctoral research is currently supported by the RMIT–Mexico International Scholarship program. Angela's project focuses on describing how gut microbes and inflammation influence brain function and behaviour in autism. Using a mouse model that carries an autism-associated gene variant, she investigates how inflammatory challenges alter behaviour and brain function. Her work has been presented at both national and international forums, including the Australasian Neuroscience Society (ANS) annual meeting in 2025 and the FENS Forum 2026 in Barcelona. A central aspect of her work explores how metabolites produced by bacteria in the gut can influence neurobiological responses, with the long-term aim of identifying microbiota-targeted therapeutic strategies for individuals with high-support needs autism. Angela's broader scientific objective is to advance mechanistic understanding of how other systems, particularly the immune system and microbiome, contribute to behavioural outcomes in neurodevelopmental conditions. She aims to bridge fundamental neurobiology with translational approaches that can lead to future therapeutic development. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

5:15
Bench Side Story avatar
Bench Side Story@BenchSideStory·Aug 8

GERONTOLOGICAL PHYSIOTHERAPY IN FALLS PREVENTION AND PREHABILITATION With Dr Rik Dawson, Gerontological Physiotherapist & Postdoctoral Researcher, Institute for Musculoskeletal Health @msk_health, University of Sydney @ & National President, Australian Physiotherapy Association @apaphysio RESEARCHER PROFILE Filmed in Sydney, Australia | August 2026 Dr Rik Dawson is a gerontological physiotherapist and health leader dedicated to improving healthy ageing through evidence-based physiotherapy, digital health and health system reform. As a Postdoctoral Researcher at the Institute for Musculoskeletal Health, University of Sydney, and President of the Australian Physiotherapy Association, he combines research and policy to improve access to high quality care for older people. With more than 30 years of experience across clinical practice Dr Dawson founded Agewell Physiotherapy, growing it into one of Australia's largest aged care physiotherapy providers before selling the business in 2020. He now leads TOP UP Therapy, a digital health company translating his PhD research into practice through an evidence-based strength and balance exercise platform that demonstrated that physiotherapist led telehealth exercise can improve mobility, reduce falls and help older people remain independent. Dr Dawson provides national leadership in aged care, workforce and primary care reform and serves on several Australian Government advisory committees, including the Strengthening Medicare Implementation Oversight Committee. He is also a member of Falls Prevention Alliance Australia and the Australian Cardiovascular Alliance. His research has attracted funding from the Medical Research Future Fund, ARIIA @ariia_org, Dementia Australia @DementiaAus and the Global Alliance for Chronic Diseases, with collaborations across Australia and Brazil. Outside work, Dr Dawson is a trained opera singer with a Bachelor of Creative Arts, a certified yoga instructor and a regular volunteer leading singalongs in residential aged care. He is married to a physiotherapist, has a daughter who is a physiotherapist and a son studying psychology. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

8:36
Bench Side Story avatar
Bench Side Story@BenchSideStory·Jul 18

APPLYING ARTIFICIAL INTELLIGENCE TO MEDICAL IMAGING FOR CARDIOVASCULAR DISEASE DETECTION Parmida Ghorbanian, PhD Candidate, University of Western Australia @uwanews & Advanced Clinical and Translational Cardiovascular Imaging, Harry Perkins Institute of Medical Research @PerkinsComms , Western Australia RESEARCHER PROFILE Filmed in Perth, Australia | July 2026 Parmida is a software engineer and biomedical scientist whose research focuses on translating novel medical imaging technologies into clinical practice to improve the diagnosis and management of cardiovascular disease. Her current work applies advanced deep learning techniques to retinal polarization-sensitive optical coherence tomography (PS-OCT) imaging, aiming to generate clinically meaningful biomarkers and predictions of cardiovascular disease. Parmida's collaboration partners include Fiona Stanley Hospital in Murdoch, Western Australia. She is the recipient of the Novel Heart Disease Imaging Through AI HDR Scholarship and has received multiple awards for her research, including the WACRA Heart-to-Vessel Showcase Award, the South Metropolitan Health Service 3-Minute Project Competition, and the Data Institute Postgraduate Student Researcher Pitch Winner award. Most recently, she was selected as a finalist in the INCITE Awards, Western Australia’s premier technology innovation awards program. Source: Supplied and adapted SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

3:52
Bench Side Story avatar
Bench Side Story@BenchSideStory·Jul 17

MEDICATION MANAGEMENT AND QUALITY USE OF MEDICINES Dr Manya Angley, Adjunct Professor, School of Health and Clinical Sciences, Health Professions Education, University of Western Australia & Director, Manya Angley Research and Consulting (MARAC), Adelaide, South Australia RESEARCHER PROFILE Filmed in Adelaide, Australia | July 2026 Adjunct Professor Manya Angley is an Advanced Practice Pharmacist. Manya spent the first 20 years of her career as a teaching and research academic at the University of South Australia. She currently works as a credentialed pharmacist and researcher through her business, Manya Angley Research and Consulting (MARAC). Her professional activities are focused in general practice, disability and aged care. She continues to undertake research in medicines safety at care transitions and quality use of medicines in the aged care and disability sectors. Manya has just stepped down as SA/NT Branch President of the Pharmaceutical Society of Australia (July 2023-June 2026) was previously vice-president (2022-2023). Manya was the proud recipient of the Pharmaceutical Society of Australia (SA/NT Branch) Pharmacist of the Year (2021) and the Australian Association of Consultant Pharmacy MIMS Consultant Pharmacist of the Year (2021). Manya holds, or has held, positions on various multidisciplinary Department of Health, Disability and Ageing (DoHDA) and the ACSQHC technical expert committees. She is regularly invited to present at National pharmacy conferences and to present to other disciplines. Manya was appointed an Adjunct Professor at the University of Western Australia in 2025. Source: Supplied SEE OTHER RESEARCHER PROFILES Bench Side Story @BenchSideStory benchsidestory.com Get your own interviews and research published on Bench Side Story benchsidestory.com/contact/

10:47